Project Details
Abstract
This study is 1) to identify the factors that will help in the clinical implementation of PGx in Qatar for guiding drug selection and dosage of several medications and 2) to determine whether it is feasible to conduct an RCT in Qatar to implement pre-emptive PGx testing utilizing a comprehensive panel of clinically relevant PGx markers.
Submitting Institute Name
Hamad Bin Khalifa University (HBKU)
| Sponsor's Award Number | PPM 08-0210-250036 |
|---|---|
| Proposal ID | EX-QNRF-PPM-61 |
| Status | Not started |
| Effective start/end date | 24/03/26 → 24/03/29 |
Collaborative partners
- Hamad Bin Khalifa University (lead)
- Hamad Medical Corporation
- Hamad Bin Khalifa University (HBKU)
Primary Theme
- Precision Health
Primary Subtheme
- PH - Preventative health
Secondary Theme
- Artificial Intelligence
Secondary Subtheme
- AI - Healthcare
Keywords
- Pharmacogenomics
- Precision medicine
- Infectious diseases
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.